DUBLIN, July 21, 2017 /PRNewswire/ —
The “Global POC Diagnostics Market 2017-2021” report has been added to Research and Markets’ offering.
The global POC diagnostics market to grow at a CAGR of 7.95% during the period 2017-2021.
Global POC Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sales, volume and value of POC diagnostics.
The latest trend gaining momentum in the market is Emerging technology of molecular diagnosis in POC. Molecular testing is used for screening specific genetic mutations. It involves analyzing the human DNA, RNA, chromosomes, specific metabolites, and proteins for detecting heritable disease-related genotypes, mutations, karyotypes, or phenotypes for clinical purposes.
The next-generation devices follow molecular techniques such as Polymerase Chain Reaction (PCR) to provide infectious disease testing result to be used in POC diagnostic device. One of the emerging molecular testing assays is the Cepheids’s GeneXpert System. This small bench-top device helps in enhancing the performance of the real-time quantitative PCR.
According to the report, one of the major drivers for this market is Growing focus on diagnosing life-threatening conditions. There is an unmet clinical need for timely diagnosis of life-threatening diseases like sepsis and acute cardiac infarction. Serious conditions with high mortality rate also incur greater patient costs and strengthen the impetus for rapid POC diagnosis.
Further, the report states that one of the major factors hindering the growth of this market is Lack of skilled professionals to carry out POC diagnosis. Most POC diagnostic tests are performed in hospitals and physician’s offices by highly skilled staff. The popularity of POC diagnostic testing is growing in developing countries. Most medical professionals lack knowledge about this technology and its benefits. There is a lack of knowledge about the ways of handling the patient during the POC testing.
- F. Hoffmann-La Roche
- Siemens Healthineers
- PTS Diagnostics
Other prominent vendors
- Accriva Diagnostics
- EKF Diagnostics
- Helena Laboratories
- iLine Microsystems
- Jant Pharmacal
- Micropoint Bioscience
- Nova Biomedical
- Philips healthcare
- Radisens Diagnostics
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Decision framework
Part 10: Drivers and challenges
Part 11: Market trends
Part 12: Vendor landscape
Part 13: Key vendor analysis
Part 14: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/mfc2kx/global_poc
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716